Mid-term syllabus of Biochem-510: Introduction to industrial management; Basic functions of management; Forms of business and organizational structure; Introduction to manufacturing; Introduction to industrial marketing; Understanding of financial management; Human resource management practices; Basics of operations and productivity; Purchasing and inventory control; Basics of plant layout; Industrial safety and risk management; Lean production; Industrial scheduling; Forecasting methods; Understanding of supply chain dynamics; Industrial operations and leadership

…. PLUS…. First 150 MCQs from chapters 2 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.

Final syllabus of Biochem-510:Overview of quality and quality control systems, Comparison between quality control and quality assurance,  The ISO 9000 standard for quality management systems, Sector-specific standards, ISO 9001 requirements, ISO 14000 series standards, Failure mode and effect analysis, Total productive maintenance, Managing quality improvement teams and projects, Statistical process control, Building and sustaining total quality organizations.

…. PLUS…. The mid-syllabus will be 30%

…. PLUS…. First 150 MCQs from chapters 2 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.

 Start preparing your presentations and assignments….. Assignment submission is the first class (of Biochem-510) of the second week of next month. The presentations will also be started after mid-term exam.

NO EXCUSE WILL BE ACCEPTED

__________________________________________________________________________________

Microsoft Teams meeting
Join on your computer, mobile app or room device

Click here to join the meeting

Meeting ID: 316 824 288 013
Passcode: WNyjeA

 __________________________________________________________________________________
 

Microsoft teams will be used whenever online classes will be held. You must make your first name as your registration number.

2017-ag-9382 Haidar Iftikhar

2017-ag-10077 Ahmad Faraz

 

BIOCHEM-510         INDUSTRIAL MANAGMEMENT AND QUALITY CONTROL                          3(3-0)

Course Learning Outcomes

  1. Interact with industries for product processing.
  2. Demonstrate the practical skills and knowledge.
  3. Learn the marketing skills of biochemical products and processes.

 Theory

Introduction to industrial management, Basic functions of management, Forms of business and organizational structure, Introduction to manufacturing, Introduction to industrial marketing, Understanding of financial management, Human resource management practices, Basics of operations and productivity, Purchasing and inventory control, Basics of plant layout, Industrial safety and risk management, Lean production, industrial scheduling, Forecasting methods, Understanding of supply chain dynamics, Industrial operations and leadership, Overview of quality and quality control systems, Comparison between quality control and quality assurance,  The ISO 9000 standard for quality management systems, Sector-specific standards, ISO 9001 requirements, ISO 14000 series standards, Failure mode and effect analysis, Total productive maintenance, Managing quality improvement teams and projects, Statistical process control, Building and sustaining total quality organizations.

Suggested Readings:

  1. Kumar, A.  2015. Industrial Management: An Introduction, Alpha Science Intl Ltd
  1. Halevi, G. Industrial Management: Control and Profit, Springer Inc. Germany.
  2. Besterfield, D.H. and C.B. Michna. 2011. Total Quality Management, Revised 3rd Edition. Pearson Education, South Asia.
  3. Kitaw, D. 2009. Industrial Management and Engineering Economy: an Introduction to Industrial Engineering, AAU Press.
Biochem-510, BS Biochem, 5TH, M-Winter 2023, Dr. Muhammad Ali; 28-08-2023
Sr.Ag No.Student’s NameGroupResearch article for presentation and 1 page summary
12021-ag-8431Eisha Zahid G1CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
22021-ag-8441Linta Shafique
32021-ag-8452Muhammad Haris
42021-ag-8458Muhammad Ramzan
52021-ag-8463Nimra Shoukat
62021-ag-8466Noor-Ul-AinG2Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
72021-ag-8472Saliha Nawaz
82021-ag-8484Abdul Qadeer
92021-ag-8485Aleena Khalid
102021-ag-8486Aleeza Tahir
112021-ag-8487Ali RazaG3Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
122021-ag-8488Amna Hamid
132021-ag-8490Anooma
142021-ag-8491Ansa Sehar
152021-ag-8492Areej Fatima Ikram
162021-ag-8493Asnan SaleemG4A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
172021-ag-8494Ayesha Hassan
182021-ag-8495Ayesha Tahir
192021-ag-8496Esha Batool
202021-ag-8497Esha Mujahid
212021-ag-8498Fatima HaiderG5Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism
222021-ag-8499Fatima Tahir
232021-ag-8500Ghazia Ashraf
242021-ag-8501Hadia Akram
252021-ag-8502Hafsa Areej
262021-ag-8503Iman FatimaG6Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells
272021-ag-8504Iman Fatima
282021-ag-8505Iqra Javed
292021-ag-8507Kashaf E Noor
302021-ag-8509Khadija Fatima
312021-ag-8510Kiran ArshadG7siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
322021-ag-8511Mahnoor
332021-ag-8512Mahnoor Fatima
342021-ag-8513Manahil Kashif
352021-ag-8514Maryam Naseer
362021-ag-8515MinahilG8An in vivo and in vitro assessment of the anti-breast cancer activity of crude extract and fractions from Prunella vulgaris L.
372021-ag-8517M.Ahtesham Muhedeen
382021-ag-8518M. Ehtisham Basel
392021-ag-8521Muhammad Shahzad
402021-ag-8525Muqaddas Raza
412021-ag-8526Naila NawazG9Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
422021-ag-8527Namal Rauf
432021-ag-8528Nimra Akram
442021-ag-8529Noor Fatima
452021-ag-8530Noor Fatima
462021-ag-8531Noreen AyeshaG10RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage
472021-ag-8532Rafia Zulfiqar
482021-ag-8533Sadaqat Ali
492021-ag-8535Toima Riaz
   
Biochem-515, BS Biochem, 5TH, E-Winter 2023, Dr. Muhammad Ali; 28-08-2023
Sr.Ag No.Student’s NameGroupResearch article for presentation and 1 page summary
12021-ag-8412Abdul Qayyum AshrafG1A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors
22021-ag-8413Abdullah Saeed
32021-ag-8414Ahmad Shahab
42021-ag-8415Aiman iftikhar
52021-ag-8416Aleesha Rubab
62021-ag-8417Ali Haider
72021-ag-8418Alina Naz
82021-ag-8419Almira EmanG2Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy
92021-ag-8420Aneeza Sattar
102021-ag-8421Aqsa Shehzadi
112021-ag-8422Areeb Fatima
122021-ag-8423Arooj Fatima
132021-ag-8424Asma
142021-ag-8425Ayesha Nadeem
152021-ag-8426Ayesha NoorG3A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors
162021-ag-8427Bushra Bibi
172021-ag-8428Chaudhry Abdul wasiq
182021-ag-8429Dildar
192021-ag-8430Eisha Noor
202021-ag-8431Eisha Zahid
212021-ag-8432Eman
222021-ag-8433Farooq HaiderG4Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
232021-ag-8434Hafiza Hamna Munawar
242021-ag-8435Hafiza khizra Noor
252021-ag-8436Hajra Ali
262021-ag-8437Hammad Jaffar Raza
272021-ag-8438Hira Rafique
282021-ag-8439Kiran Shehzadi
292021-ag-8440Laraib Mubarik
302021-ag-8441Linta ShafiqueG5Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer
312021-ag-8442Maham Shafarash
322021-ag-8443Malaika Noor
332021-ag-8444Mariam Zia
342021-ag-8445Marium Ashfaq
352021-ag-8446Mehak Mouazam
362021-ag-8447Mehrab Fatima
372021-ag-8448Mian Muhammad Farrukh RashidG6L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
382021-ag-8449Mina Fatima
392021-ag-8450Muhammad Adnan Atta
402021-ag-8451Muhammad Arslan Tahir
412021-ag-8452Muhammad Haris
422021-ag-8453Muhammad Hashim
432021-ag-8454Muhammad Hashim
442021-ag-8455Muhammad MukarramG7BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
452021-ag-8456Muhammad Mustafa
462021-ag-8457Muhammad Rafay Ahmad
472021-ag-8458Muhammad Ramzan
482021-ag-8459Muhammad Umair
492021-ag-8460Muhammad Waleed Hashir
502021-ag-8461Mujahid Ali
512021-ag-8462Nida AslamG8The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/ MAPK signaling pathway
522021-ag-8463Nimra Shoukat
532021-ag-8464Noor Fakhar
542021-ag-8465Noor Fatima
552021-ag-8466Noor-ul-Ain
562021-ag-8467Rabeea Rafhan
572021-ag-8468Saba Irshad
582021-ag-8469Sadaf JavedG9Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model
592021-ag-8470Sadia Altaf
602021-ag-8471Saira Zafar
612021-ag-8472Saliha Nawaz
622021-ag-8473Saman Bashir
632021-ag-8474Sana Bushra
642021-ag-8475Syeda Sajjal Bukhari
652021-ag-8476Sehar Anees
662021-ag-8477Sheraz NazirG10ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression
672021-ag-8478Sidra-TUL-Muntaha
682021-ag-8479Taiba Amin
692021-ag-8480Tanzeela Imran
702021-ag-8481Tuba Ahmad
712021-ag-8482UM-E-LAILA
722021-ag-8483Usman Ghani

Add your first comment to this post

Comments are closed.